PATENT CLAIM ANALYSIS

Application Number: 15889703
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "093700"]

Abstract:
The invention is a therapeutic method for repairing damaged pancreas. The method comprises administrating Epigallocatechin gallate (EGCG) of green tea and a plurality of adipose-derived stem cells (ADSC). And Epigallocatechin gallate (EGCG) of green tea enhances the ability of the adipose-derived stem cells to repair damaged tissue.

Claim (Index 7):
The method of  claim 1 , wherein the pretreated adipose-derived stem cells have higher viability in a high glucose environment, wherein the high glucose environment means the glucose concentration is 22 mM\u02dc44 mM, mainly 33 mM, the high viability is 80%\u02dc100%.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.64706
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15604201', '13814489', '14664441', '14715098', '10785720']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7521289019570871
- 35 USC 102 Novelty (BERT): 0.5064120850133241
- Combined Prediction Score: 0.727557220262711
- Mean Citation Score: 222.14501600000003
- Max Citation Score: 234.45697
- Similarity Product: 148.16177505619825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test